本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Hemab Therapeutics Holdings, Inc.

49.65
+2.986.39%
盤後49.650.00000.00%19:30 EDT
成交量:52.72萬
成交額:2,572.39萬
市值:23.19億
市盈率:-27.86
高:50.36
開:46.67
低:46.58
收:46.67
52周最高:55.42
52周最低:23.00
股本:4,670.54萬
流通股本:1,675.00萬
量比:1.63
換手率:3.15%
股息:- -
股息率:- -
每股收益(TTM):-1.7820
每股收益(LYR):-67.5613
淨資產收益率:-46.99%
總資產收益率:-30.11%
市淨率:5.10
市盈率(LYR):-0.73

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/21

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/11

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/30

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/28

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/10

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933